Clinical Trial Update: A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase II single-arm study evaluating carbon ion radiotherapy combined with atezolizumab and bevacizumab for advanced hepatocellular carcinoma, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Yonsei University | Conditions: Hepatocellular Carcinoma, Liver Neoplasms | Phase 2 | Status: RECRUITING